These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32606067)

  • 21. Update of dialysis initiation timing in end stage kidney disease patients: is it a resolved question? A systematic literature review.
    Jia X; Tang X; Li Y; Xu D; Moreira P
    BMC Nephrol; 2023 Jun; 24(1):162. PubMed ID: 37286965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies.
    Pilz S; Iodice S; Zittermann A; Grant WB; Gandini S
    Am J Kidney Dis; 2011 Sep; 58(3):374-82. PubMed ID: 21636193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
    Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies.
    Hanlon P; Jani BD; Nicholl B; Lewsey J; McAllister DA; Mair FS
    PLoS Med; 2022 Mar; 19(3):e1003931. PubMed ID: 35255092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney disease.
    Hydes T; Buchanan R; Kennedy OJ; Fraser S; Parkes J; Roderick P
    BMJ Open; 2020 Sep; 10(9):e040970. PubMed ID: 32988952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
    Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H;
    Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychosocial interventions for preventing and treating depression in dialysis patients.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between sarcopenia and clinical outcomes in chronic kidney disease patients: A systematic review and meta-analysis.
    Ribeiro HS; Neri SGR; Oliveira JS; Bennett PN; Viana JL; Lima RM
    Clin Nutr; 2022 May; 41(5):1131-1140. PubMed ID: 35430544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of oral alkali drug therapy on clinical outcomes in pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis.
    Shi H; Su X; Yan B; Li C; Wang L
    Ren Fail; 2022 Dec; 44(1):106-115. PubMed ID: 35176947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse Pregnancy Outcomes and Long-term Maternal Kidney Disease: A Systematic Review and Meta-analysis.
    Barrett PM; McCarthy FP; Kublickiene K; Cormican S; Judge C; Evans M; Kublickas M; Perry IJ; Stenvinkel P; Khashan AS
    JAMA Netw Open; 2020 Feb; 3(2):e1920964. PubMed ID: 32049292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients without diabetes: a systematic review and meta-analysis of randomised placebo-controlled trials.
    Tsai WC; Hsu SP; Chiu YL; Yang JY; Pai MF; Ko MJ; Tu YK; Hung KY; Chien KL; Peng YS; Wu HY
    BMJ Open; 2022 Oct; 12(10):e060655. PubMed ID: 36241355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden.
    Swartling O; Rydell H; Stendahl M; Segelmark M; Trolle Lagerros Y; Evans M
    Am J Kidney Dis; 2021 Aug; 78(2):190-199.e1. PubMed ID: 33434591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Intensive Blood Pressure Control and Kidney Disease Progression in Nondiabetic Patients With Chronic Kidney Disease: A Systematic Review and Meta-analysis.
    Tsai WC; Wu HY; Peng YS; Yang JY; Chen HY; Chiu YL; Hsu SP; Ko MJ; Pai MF; Tu YK; Hung KY; Chien KL
    JAMA Intern Med; 2017 Jun; 177(6):792-799. PubMed ID: 28288249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial.
    Wheeler DC; Stefánsson BV; Jongs N; Chertow GM; Greene T; Hou FF; McMurray JJV; Correa-Rotter R; Rossing P; Toto RD; Sjöström CD; Langkilde AM; Heerspink HJL;
    Lancet Diabetes Endocrinol; 2021 Jan; 9(1):22-31. PubMed ID: 33338413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.
    Helou N; Dwyer A; Shaha M; Zanchi A
    JBI Database System Rev Implement Rep; 2016 Jul; 14(7):169-207. PubMed ID: 27532796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Multimorbidity with Mortality and Healthcare Utilization in Chronic Kidney Disease.
    Bowling CB; Plantinga L; Phillips LS; McClellan W; Echt K; Chumbler N; McGwin G; Vandenberg A; Allman RM; Johnson TM
    J Am Geriatr Soc; 2017 Apr; 65(4):704-711. PubMed ID: 27880003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.
    Srivastava A; Kaze AD; McMullan CJ; Isakova T; Waikar SS
    Am J Kidney Dis; 2018 Mar; 71(3):362-370. PubMed ID: 29132945
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.